Oral Delivery of Vaccines: From Nanocarriers to Biomodulators

Tuesday, July 1, 2025

4:30 PM - 4:35 PM EDT

Learning Objectives:

At the completion of this activity, participants will know

Identify features of mesoporous aluminosilicate nanoadjuvants enhancing antigen delivery.
Explain how nanoadjuvants induce pyroptosis and activate tissue-resident memory T cells.
Evaluate nanotechnology-based platforms for oral vaccine delivery in cancer prevention.

Chengzhong Yu, Phd – Group Leader, Australian Institute for Bioengineering and Nanotechnology, University of Queensland